Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with dukes' stage B and C colorectal cancer

Journal of Clinical Oncology

Volumn 29, Issue 12, 2011, Pages 1547-1555

  Iinuma, Hisae ^a,b,c,d,e,f   Watanabe, Toshiaki ^a,b,c,d,e,f   Mimori, Koshi ^a,b,c,d,e,f   Adachi, Miki ^a,b,c,d,e,f   Hayashi, Naoko ^a,b,c,d,e,f   Tamura, Junko ^a,b,c,d,e,f   Matsuda, Keiji ^a,b,c,d,e,f   Fukushima, Ryoji ^a,b,c,d,e,f   Okinaga, Kota ^a,b,c,d,e,f   Sasako, Mitsuru ^a,b,c,d,e,f   Mori, Masaki ^a,b,c,d,e,f  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b International University of Health and Welfare Mita Hospital   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

^f OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD133 ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 20; MESSENGER RNA;

AGED; ARTICLE; BLOOD; CANCER RECURRENCE; CANCER STAGING; CANCER STEM CELL; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RECTUM CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

AGED; ANTIGENS, CD; CARCINOEMBRYONIC ANTIGEN; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COLECTOMY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GLYCOPROTEINS; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; KERATIN-19; KERATIN-20; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; PATIENT SELECTION; PEPTIDES; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955030814     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.30.5151     Document Type: Article

References (37)

1. Winawer S, Fletcher R, Rex D, et al: Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124:544-560, 2003 (Pubitemid 36169269)
2. Safi F, Beyer HG: The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detect Prev 17:417-424, 1993
3. André T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351, 2004 (Pubitemid 38702845)
4. Meropol NJ, Schulman KA: Cost of cancer care: Issues and implications. J Clin Oncol 25:180-186, 2007 (Pubitemid 350003031)
5. Chung KY, Kelsen D: Adjuvant therapy for stage II colorectal cancer: Who and with what? Curr Treat Options Gastroenterol 9:272-280, 2006 (Pubitemid 43853442)
6. Engell HC: Cancer cells in the circulating blood: A clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation [in Danish]. Ugeskr Laeger 117:822-823, 1955
7. Peach G, Kim C, Zacharakis E, et al: Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: A systematic review. Br J Cancer 102:1327-1334, 2010
8. Riethdorf S, Wikman H, Pantel K: Review: Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 123:1991-2006, 2008
9. Iinuma H, Okinaga K, Egami H, et al: Usefulness and clinical significance of quantitative realtime RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol 28:297-306, 2006
10. Cristofanilli M, Budd GT, Ellis MJ, et al: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781-791, 2004 (Pubitemid 39095313)
11. Cohen SJ, Punt CJ, Iannotti N, et al: Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26:3213-3221, 2008
12. Todaro M, Francipane MG, Medema JP, et al: Colon cancer stem cells: Promise of targeted therapy. Gastroenterology 138:2151-2162, 2010
13. Aktas B, Tewes M, Fehm T, et al: Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 11:R46, 2009
14. O'Brien CA, Pollett A, Gallinger S, et al: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110, 2007 (Pubitemid 46067310)
15. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al: Identification and expansion of human colon-cancerinitiating cells. Nature 445:111-115, 2007 (Pubitemid 46067311)
16. Pantel K, Brakenhoff RH, Brandt B: Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329-340, 2008 (Pubitemid 351596394)
17. Nakamura K, Iinuma H, Aoyagi Y, et al: Predictive value of cancer stem-like cells and cancerassociated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery. Oncology 78:309-315, 2010
18. Lurje G, Schiesser M, Claudius A, et al: Circulating tumor cells in gastrointestinal malignancies: Current techniques and clinical implications. J Oncol [epub ahead of print on November 5, 2009]
19. Pantel K, Schlimok G, Angstwurm M, et al: Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3:165-173, 1994
20. Cristofanilli M, Hayes DF, Budd GT, et al: Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23:1420-1430, 2005
21. Guller U, Zajac P, Schnider A, et al: Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 236:768-776, 2002 (Pubitemid 35403232)
22. Wang J-Y, Wu C-H, Lu C-Y, et al: Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RTPCR: Significance of the prediction of postoperative metastasis. World J Surg 30:1007-1013, 2006 (Pubitemid 43824411)
23. Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 9:265-273, 2009
24. Sieuwerts AM, Kraan J, Bolt J, et al: Antiepithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 101:61-66, 2009
25. Mani SA, Guo W, Liao MJ, et al: The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133:704-715, 2008 (Pubitemid 351636299)
26. Alix-Panabié res C, Vendrell JP, Pellé O, et al: Detection and characterization of putative metastatic precursor cells in cancer patients. Clin Chem 53:537-539, 2007 (Pubitemid 46447957)
27. Braun S, Kentenich C, Janni W, et al: Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 18:80-86, 2000 (Pubitemid 30036339)
28. Riethdorf S, Pantel K: Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: Current state of detection and characterization. Pathobiology 75:140-148, 2008 (Pubitemid 351820732)
29. Gudjonsson T, Villadsen R, Nielsen HL, et al: Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev 16:693-706, 2002 (Pubitemid 34274039)
30. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983-3988, 2003 (Pubitemid 36418143)
31. Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828, 2003 (Pubitemid 37187480)
32. Richardson GD, Robson CN, Lang SH, et al: CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117:3539-3545, 2004 (Pubitemid 39206394)
33. Du L, Wang H, He L, et al: CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 14:6751-6760, 2008
34. Rafii S, Lyden D, Benezra R, et al: Vascular and hematopoietic stem cell: Novel targets for antiangiogenesis therapy? Nat Rev Cancer 2:826-835, 2002 (Pubitemid 37328901)
35. Natori T, Sata M, Washida M, et al: G-CSF stimulates angiogenesis and promotes tumor growth: Potential contribution of bone marrowderived endothelial progenitor cells. Biochem Biophys Res Commun 297:1058-1061, 2002 (Pubitemid 35230360)
36. Spring H, Schüler T, Arnold B, et al: Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci U S A 102:18111-18116, 2005 (Pubitemid 41798510)
37. Rahbari NN, Aigner M, Thorlund K, et al: Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 138:1714-1726, 2010